OXOS Medical Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • OXOS Medical's estimated annual revenue is currently $24.6M per year.(i)
  • OXOS Medical's estimated revenue per employee is $251,000

Employee Data

  • OXOS Medical has 98 Employees.(i)
  • OXOS Medical grew their employee count by 38% last year.

OXOS Medical's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.3M29N/AN/AN/A
#2
$104.7M4173%N/AN/A
#3
$6M24-23%N/AN/A
#4
$5M400%$16MN/A
#5
$6M24-23%N/AN/A
#6
$10.8M435%N/AN/A
#7
$3M240%$50MN/A
#8
$10M40-13%N/AN/A
#9
$5M2011%N/AN/A
#10
$17.6M703%N/AN/A
Add Company

What Is OXOS Medical?

OXOSⓇ Medical (OXOS) designs, develops and manufactures cloud-connected medical imaging solutions, enabling medical professionals to determine radiographic diagnoses at the point-of-care. In 2016 Dr. Gregory Kolovich, Chief Medical Officer and Evan Ruff, Chief Executive Officer, co-founded the company in Savannah, Georgia as Micro C, LLC. and then established its headquarters in Atlanta, Georgia. In 2020 they converted Micro C, LLC. to OXOS Medical, Inc., a C corporation. In 2021 OXOS entered the $40 billion U.S. diagnostic radiology market with U.S. Food and Drug Administration (FDA) 510(k) clearance of its Micro CⓇ Medical Imaging System, a handheld, dynamic digital radiography (DDR) system. The company will develop and launch additional products utilizing the OXOS Platform—a system for on-demand image management, telehealth collaboration, and delivery of artificial intelligence (AI) diagnostics, among other workloads. The Micro C is available now with additional information available on the OXOS website: https://oxos.com/ or by email to info@oxos.com.

keywords:N/A

N/A

Total Funding

98

Number of Employees

$24.6M

Revenue (est)

38%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$20.6M981%N/A
#2
$14.2M9810%N/A
#3
$24.5M985%N/A
#4
$31.7M98-9%N/A
#5
$14.2M98N/AN/A